Back to top
more

Organigram Holdings Inc. (OGI)

(Delayed Data from NSDQ)

$3.03 USD

3.03
10,989,886

-0.05 (-1.62%)

Updated Feb 26, 2021 04:00 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.41%
2Buy17.88%
3Hold9.48%
4Sell5.03%
5Strong Sell1.87%
S&P50010.70%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth B Momentum D VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (165 out of 253)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for OGI More Info

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Organigram Holdings Inc. falls in the month of August.

All items in Millions except Per Share data.

8/31/2020 8/31/2019 8/31/2018 8/31/2017 8/31/2016
Assets          
Cash & Equivalents 56 36 102 NA NA
Receivables 13 13 3 NA NA
Notes Receivable 0 0 0 NA NA
Inventories 53 86 51 NA NA
Other Current Assets 5 13 4 NA NA
Total Current Assets 127 148 159 NA NA
Net Property & Equipment 184 165 77 NA NA
Investments & Advances 11 8 0 NA NA
Other Non-Current Assets 0 0 0 NA NA
Deferred Charges 1 0 1 NA NA
Intangibles 1 1 0 NA NA
Deposits & Other Assets 0 0 0 NA NA
Total Assets 324 323 237 NA NA
Liabilities & Shareholders Equity 8/31/2020 8/31/2019 8/31/2018 8/31/2017 8/31/2016
Notes Payable 0 0 0 NA NA
Accounts Payable 13 30 8 NA NA
Current Portion Long-Term Debt 9 3 0 NA NA
Current Portion Capital Leases 0 0 0 NA NA
Accrued Expenses 0 0 0 NA NA
Income Taxes Payable 0 0 0 NA NA
Other Current Liabilities 0 0 0 NA NA
Total Current Liabilities 22 33 9 NA NA
Mortgages 0 0 0 NA NA
Deferred Taxes/Income 0 8 6 NA NA
Convertible Debt 0 0 75 NA NA
Long-Term Debt 77 35 2 NA NA
Non-Current Capital Leases 0 0 0 NA NA
Other Non-Current Liabilities 2 1 0 NA NA
Minority Interest (Liabilities) 0 0 0 NA NA
Total Liabilities 101 77 92 NA NA
Shareholders Equity 8/31/2020 8/31/2019 8/31/2018 8/31/2017 8/31/2016
Preferred Stock 0 0 0 NA NA
Common Stock (Par) 313 240 124 NA NA
Capital Surplus 0 0 0 NA NA
Retained Earnings -108 -7 1 NA NA
Other Equity 18 13 20 NA NA
Treasury Stock 0 0 0 NA NA
Total Shareholder's Equity 223 247 145 NA NA
Total Liabilities & Shareholder's Equity 324 323 237 NA NA
Total Common Equity 223 247 145 0 0
Shares Outstanding 194.50 156.10 NA NA NA
Book Value Per Share 1.15 1.58 0.00 0.00 0.00

Fiscal Year End for Organigram Holdings Inc. falls in the month of August.

All items in Millions except Per Share data.

11/30/2020 8/31/2020 5/31/2020 2/29/2020 11/30/2019
Assets          
Cash & Equivalents 102 56 32 31 26
Receivables 11 13 9 16 16
Notes Receivable 0 0 0 0 0
Inventories 41 53 72 107 95
Other Current Assets 4 5 3 4 9
Total Current Assets 158 127 116 158 145
Net Property & Equipment 185 184 179 212 197
Investments & Advances 14 11 11 7 8
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 1 1 0 1 0
Intangibles 1 1 2 2 2
Deposits & Other Assets 0 0 2 1 2
Total Assets 360 324 310 381 355
Liabilities & Shareholders Equity 11/30/2020 8/31/2020 5/31/2020 2/29/2020 11/30/2019
Notes Payable 0 0 0 0 0
Accounts Payable 13 13 18 20 32
Current Portion Long-Term Debt 46 9 5 64 5
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 59 22 23 85 37
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 8 8
Convertible Debt 0 0 0 0 0
Long-Term Debt 41 77 56 0 59
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 17 2 2 2
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 118 101 81 94 106
Shareholders Equity 11/30/2020 8/31/2020 5/31/2020 2/29/2020 11/30/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 360 313 288 283 241
Capital Surplus 0 0 0 0 0
Retained Earnings -136 -108 -76 -13 -7
Other Equity 18 18 17 17 15
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 242 223 229 287 249
Total Liabilities & Shareholder's Equity 360 324 310 381 355
Total Common Equity 242 223 229 287 249
Shares Outstanding 232.00 194.50 175.70 173.00 156.10
Book Value Per Share 1.04 1.15 1.30 1.66 1.59